Brookfield Asset Management Inc. Bausch Health Companies Inc. Transaction History

Brookfield Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 25, 2023	BUY	$6.28 - $9.85 $722,758 - $1.13 Million	115,089 New	115,089 $932,000
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $722,758 - $1.13 Million	115,089 New	115,089 $932,000
Q3 2021 Nov 16, 2021	SELL	$25.04 - $30.06 $3.34 Million - $4.01 Million	-133,458 Reduced 52.68%	119,893 $3.34 Million
Q2 2021 Aug 17, 2021	BUY	$27.43 - $32.7 $5.12 Million - $6.11 Million	186,804 Added 280.71%	253,351 $7.43 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $224,620 - $361,368	-10,511 Reduced 13.64%	66,547 $2.11 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $1.18 Million - $1.63 Million	77,058 New	77,058 $1.6 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.85B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.